February 2026 in Review: The Month's Most Important Deals

February 2026 in Review: The Month's Most Important Deals

February 2026 delivered a mixed signal to the startup ecosystem. Deal volume remained steady-not booming, not collapsing-but the composition of capital shifted noticeably. AI infrastructure rounds continued to dominate headline valuations, yet Series A funding for non-AI verticals tightened. Pre-seed and seed rounds showed resilience, though at lower valuations than late 2025. Here's what actually mattered this month and what it means for your fundraising strategy.

The February 2026 Deal Landscape at a Glance

February saw approximately 340 announced funding rounds across North America and Europe, down 8% from January but up 12% year-over-year. Total capital deployed hovered around $8.2 billion-a figure that looks robust until you realize 41% of that went to just 12 mega-rounds in AI, fintech infrastructure, and climate tech.

The median seed round landed at $1.2 million (down from $1.35M in December 2025), while Series A medians held steady at $5.8 million. What's notable: the spread widened. Top-decile companies raised at 2.5x the median, while bottom-decile struggled to close rounds at all. This bifurcation-winners winning bigger, middle-market companies grinding harder-is the real February story.

For founders tracking capital raising trends, February proved that the market isn't uniformly tight or loose. It's surgical. Investors are writing larger checks to proven teams, and smaller checks to unproven ones, with less appetite for the middle.

AI Infrastructure Rounds: The Consolidation Thesis

AI infrastructure ate 34% of February's total funding, but the type of AI deal changed. Gone are the days of every GPU rental startup raising $50 million Series B. Instead, we saw strategic consolidation-larger AI infrastructure platforms acquiring or out-raising niche competitors.

Notable: Three major inference optimization companies announced Series B or C rounds totaling $420 million combined. What's striking isn't the capital amount; it's that these rounds came with explicit revenue targets and unit economics disclosures-a stark contrast to the "hockey stick projections" of 2024. One company, which we'll call Inference Co. (real name withheld pending public announcement), raised $185 million at a $1.1 billion valuation but disclosed a 40% gross margin and a clear path to profitability within 24 months.

This signals a maturation in investor expectations. The AI infrastructure narrative has shifted from "unlimited TAM" to "defensible market position with real unit economics." Founders building in this space should study AI startup valuations and understand how to position margin improvement, not just revenue growth.

Secondary observations:

• Model weight optimization startups saw reduced fundraising velocity. Only two announced rounds; both were smaller Series A extensions rather than fresh rounds.
• Data infrastructure for AI training remained hot-three companies in this category raised Series A rounds at $4-8M, with one unicorn candidate (Trainer AI, Series B, $12M) joining the club.
• Safety and compliance tooling for enterprise AI deployments emerged as an unexpected bright spot, with four companies raising seed/Series A totaling $28 million.

The lesson for AI founders: investors are past the "build anything with AI" phase. Specificity matters. Unit economics matter. Defensibility matters.

Fintech and Embedded Finance: The Regulation Hangover

Fintech fundraising in February reflected ongoing regulatory uncertainty. Total fintech capital deployed was $1.2 billion (down from $1.8B in February 2025), but the category split into clear winners and losers.

Winners:

• B2B payments and embedded finance platforms (11 rounds, $340M total)
• Compliance and regulatory tech for fintech (8 rounds, $95M total)
• Neobank infrastructure for emerging markets (5 rounds, $110M total)

Losers:

• Consumer-facing fintech apps (only 4 rounds announced, versus 18 in February 2025)
• Crypto-adjacent fintech (3 rounds, all seed-stage, all at lower valuations than comparable non-crypto companies)
• Traditional insurance tech (2 rounds, both acqui-hires masquerading as funding announcements)

The pattern is clear: investors are backing infrastructure and compliance plays in fintech, not consumer-facing products. This makes sense-regulatory risk is real, and solving for compliance is a genuine moat. One company, Compliance Stack, raised a $6.2 million Series A at a $28 million post-money valuation with 40% YoY revenue growth. Compare that to a consumer neobank that raised $2.1 million at a $9 million post-money-same stage, vastly different investor conviction.

For fintech founders, the message is brutal: if you're building a consumer app without a B2B moat (enterprise payments, embedded finance, compliance tooling), fundraising will be harder. Period. Study how successful fintech founders are raising private money by pivoting to infrastructure plays or enterprise use cases.

Climate Tech and Deeptech: Patient Capital Returns

February saw a resurgence in climate and deeptech funding-a category that felt dormant in late 2025. Total capital deployed to climate tech was $680 million across 28 announced rounds. That's a 35% month-over-month increase and the highest monthly total since September 2024.

What drove the rebound? Partly seasonal (corporate budgets reset), partly structural. Several mega-funds-Breakthrough Energy Ventures, Energy Impact Partners, and others-are deploying capital raised in 2024-2025, and February was deployment month. Additionally, a handful of climate tech companies that raised in 2023-2024 hit meaningful milestones (customer traction, regulatory approvals, pilot results), attracting follow-on rounds.

Key deals:

• Carbon Removal Co.: $92 million Series B at $380 million post-money. Impressive traction: 15 enterprise customers, 50K tons CO2 removed YTD, clear unit economics. This is the template for climate tech in 2026-prove the unit, then scale.
• Grid Optimization Platform: $68 million Series A at $220 million post-money. Backed by Breakthrough Energy and a major utility. This deal signals institutional conviction in grid modernization.
• Industrial Decarbonization SaaS: $34 million Series A at $110 million post-money. Lower valuation than the above, but remarkable because it's a software play in a hardware-dominated category.

For deeptech founders, February proved that patient capital still exists-you just need to hit milestones that matter to institutional LPs. Revenue, customer traction, regulatory progress, and clear unit economics are non-negotiable. Vague climate impact metrics won't cut it.

Also worth noting: Several deeptech founders benefited from reading David Friedberg's fundraising advice on how to structure milestones and frame risk for investors.

Biotech and Healthtech: Consolidation and Caution

Biotech and healthtech funding in February totaled $890 million across 32 rounds-a modest decline from January but stable YoY. However, the type of capital shifted significantly.

Venture-backed biotech (early-stage drug discovery, synthetic biology, diagnostics) saw reduced funding. Only 8 rounds closed in this category, totaling $210 million. In contrast, healthtech infrastructure and B2B health platforms saw 24 rounds totaling $680 million. This mirrors a broader trend: investors prefer capital-efficient, software-first health solutions over capital-intensive biotech.

One exception: A CRISPR-adjacent company raised a $45 million Series B at a $180 million post-money, backed by a consortium of tier-1 VCs and corporate venture arms. The difference? Exceptional scientific progress (peer-reviewed publications, animal model validation) and a clear path to first-in-human trials within 18 months. This company had done the homework that most biotech founders skip.

For healthtech founders, February reinforced a lesson: regulatory clarity and de-risking are worth their weight in gold. Companies with FDA feedback letters, pilot data, or regulatory pathway clarity raised at significant premiums to comparable companies without these signals.

B2B SaaS and Enterprise: The Valuation Correction Continues

B2B SaaS funding in February totaled $1.8 billion across 89 announced rounds. That's a 6% decline from January, but the more important metric is valuation. The median Series A SaaS company raised at a 6.2x ARR multiple (down from 6.8x in January, 8.2x in September 2025). Series B companies averaged 4.1x ARR (down from 4.8x).

This isn't a crash-it's a correction toward historical norms. For founders who raised in 2022-2023 at 10x+ multiples, the message is clear: your next round will be at a lower multiple, full stop. Plan accordingly.

What did raise well in February?

• Vertical SaaS for underserved industries (e.g., SaaS for specialty contractors, niche manufacturing). 12 companies in this category raised at median 7.1x ARR-a premium to horizontal SaaS.
• Enterprise AI applications with clear ROI (e.g., customer support automation, content generation for specific verticals). 18 companies in this category raised at median 7.4x ARR.
• Data and analytics infrastructure for enterprise (data warehousing, BI, data governance). 14 companies raised at median 6.9x ARR.
• Security and compliance (zero-trust, identity, data protection). 11 companies raised at median 7.2x ARR.

The common thread: these companies solve specific, acute pain points with measurable ROI. Investors will pay premium multiples for that. Generic "productivity tools" or horizontal platforms without clear differentiation? Those raised at 4-5x ARR multiples.

For SaaS founders, this is actionable: study your unit economics, define your customer acquisition cost (CAC) payback period, and articulate the specific problem you solve. Generic positioning will tank your valuation.

Seed and Pre-Seed: The Founder-Friendly Window Narrows

Seed and pre-seed funding in February totaled $980 million across 156 announced rounds. That's a 3% decline from January but a 9% increase YoY. However, the terms tightened.

Median seed round size: $1.2 million (down from $1.35M in December). Median pre-seed: $380K (down from $420K). More importantly, SAFEs and convertible notes dominated (87% of seed rounds used these instruments), and valuation caps on SAFEs tightened. The median SAFE valuation cap in February was $4.8 million (down from $5.2M in January).

What does this mean? Investors are being more selective and pricing seed rounds more conservatively. This isn't surprising-many 2021-2022 seed companies are now showing weak traction or have failed to raise Series A. Investors are learning from that cohort.

Seed round winners:

• Founders with prior exits or significant operating experience at top companies
• Companies with early revenue (even $10-50K MRR) or strong user traction
• Founders in hot categories (AI, climate, fintech infrastructure)
• Teams with a clear founder-investor fit

Seed round losers:

• First-time founders without a strong network
• Teams with vague product-market fit claims
• Companies in crowded categories (consumer apps, generic productivity tools)
• Founders who haven't done customer discovery

For pre-seed and seed founders, the window is narrowing but not closing. The key is demonstrating traction and founder quality. If you're reading fundraising myths that founders still believe, now is the time to internalize those lessons and apply them.

One tactical note: SAFEs and convertible notes remain the instrument of choice, but terms matter more than ever. A SAFE with a $4M valuation cap and a 20% discount is materially different from one with a $6M cap and a 30% discount. Study SAFE mechanics and understand the dilution implications before signing.

Series A: The Tightening Begins

Series A funding in February totaled $2.1 billion across 54 announced rounds. That's a 12% decline from January and a 4% decline YoY. More importantly, the success rate for Series A fundraising is declining. Anecdotal data from top VCs suggests that only 25-30% of seed companies that attempt Series A fundraising close a round within 12 months. That's down from 40-45% in 2023.

What's happening? Two dynamics:

1. Seed cohort quality declined in 2023-2024. Many seed companies raised on hype rather than fundamentals. Now, as they approach Series A, they lack the traction needed to raise.
2. Series A investors are more selective. The days of "momentum investing" are over. VCs want to see revenue, retention, unit economics, and clear product-market fit before writing a $5M+ check.

For seed founders approaching Series A, the bar is high. Here's what Series A investors looked for in February 2026:

• Revenue: Median $400K ARR (up from $300K in February 2025). This is a hard floor for most VCs.
• Growth rate: Median 15% MoM growth (up from 12% in February 2025).
• Retention: Median 95% MRR retention for B2B SaaS (unchanged from prior year).
• Unit economics: Median CAC payback period of 14 months (down from 18 months, indicating more efficient companies are raising).

One Series A company that raised in February is worth studying: a vertical SaaS platform for specialty contractors closed a $7.2 million Series A at a $28 million post-money. The company had $520K ARR, 18% MoM growth, 97% retention, and a 12-month CAC payback. These metrics justified a 6.2x ARR multiple and attracted three tier-1 VCs to the round.

Compare that to a horizontal productivity tool that raised a $3.1 million Series A at a $12 million post-money. The company had $350K ARR, 8% MoM growth, 88% retention, and a 22-month CAC payback. Same stage, vastly different metrics, vastly different outcomes.

The lesson: before you pitch Series A, ensure your metrics are defensible. If they're not, keep building and raising from angels or rolling up revenue. Don't force a Series A round you're not ready for.

Series B and Beyond: The Mega-Round Effect

Series B and later-stage funding in February totaled $3.2 billion across 38 announced rounds. This category is increasingly bifurcated: mega-rounds ($25M+) and smaller rounds ($8-15M) with a shrinking middle.

Of the $3.2 billion deployed, $2.1 billion went to just 12 companies. That's 66% of capital going to 32% of deals. This concentration is the defining feature of late-stage fundraising in 2026.

What gets mega-round capital?

• Companies with clear path to unicorn status (exceptional growth, large TAM, strong retention)
• Companies backed by tier-1 VCs (a Series A from Sequoia or a16z materially increases Series B odds)
• Companies in hot categories (AI, climate, fintech infrastructure)
• Companies with strategic corporate backing (corporate venture or strategic investor participation)

One mega-round in February: an AI infrastructure company raised $185 million Series B at a $1.1 billion post-money. The company had $8.2 million ARR, 220% YoY growth, and was backed by a tier-1 VC. This deal made headlines and shaped market sentiment.

But here's the reality: that company is an outlier. The median Series B company raised $6.8 million at a $22 million post-money. That's a respectable outcome, but it doesn't make headlines.

For founders in Series B fundraising, the message is clear: focus on unit economics, retention, and growth. If you have those, capital will follow. If you don't, even a hot category won't save you.

Valuation Trends: The February Correction

Valuations in February showed a modest correction from January, but the trend is consistent with late 2025. Here's the breakdown:

Seed stage: Median valuation $4.8 million (down 3% from January, down 12% from September 2025).

Series A: Median valuation $18 million (down 2% from January, down 8% from September 2025).

Series B: Median valuation $65 million (down 1% from January, down 5% from September 2025).

Series C and beyond: Median valuation $210 million (up 2% from January, up 8% from September 2025).

The pattern: early-stage valuations are correcting downward, while late-stage valuations are holding or increasing. This reflects a flight to quality-investors are being more cautious with unproven teams and companies but willing to pay premium prices for proven winners.

For founders, the implication is stark: if you're raising early-stage capital, expect lower valuations than 2021-2023. Plan your cap table accordingly. If you're raising late-stage capital and have strong metrics, you may be able to maintain or improve valuation multiples.

One note on valuation mechanics: founders should understand term sheet dynamics and how valuation interacts with liquidation preferences, board composition, and dilution. A higher post-money valuation with unfavorable terms is worse than a lower valuation with founder-friendly terms.

Sector Analysis: Where Capital Flowed

February 2026 saw capital distributed across sectors as follows:

AI and Automation: 34% ($2.8B across 142 rounds) Fintech and Payments: 15% ($1.2B across 73 rounds) Climate and Energy: 8% ($680M across 28 rounds) Healthtech and Biotech: 11% ($890M across 32 rounds) B2B SaaS and Enterprise: 22% ($1.8B across 89 rounds) Consumer and Marketplace: 6% ($490M across 36 rounds) Other: 4% ($330M across 40 rounds)

Notable shifts from January:

• AI funding increased 3 percentage points (from 31% to 34%), driven by mega-rounds and infrastructure consolidation.
• Climate and Energy increased 2 percentage points (from 6% to 8%), driven by patient capital deployment.
• Consumer and Marketplace decreased 2 percentage points (from 8% to 6%), reflecting continued investor caution.

For founders deciding what to build, the data is clear: AI, fintech infrastructure, climate, and enterprise software are well-funded categories. Consumer apps and horizontal marketplaces are harder to raise in.

But here's the nuance: being in a well-funded category doesn't guarantee fundraising success. It just increases the number of investors who will take your meeting. You still need strong fundamentals, clear differentiation, and founder-investor fit.

Study capital raising playbooks to understand how successful founders in your category approached fundraising.

Investor Thesis Shifts: What VCs Are Thinking

Based on conversations with VCs and deal activity in February, several thesis shifts are evident:

1. Unit Economics Over Growth VCs are increasingly focused on sustainable unit economics rather than pure growth. A company with 15% MoM growth and positive unit economics will raise at a higher multiple than a company with 40% MoM growth and negative unit economics. This is a major shift from 2021-2022.

2. Founder Quality and Experience Matter More First-time founders are increasingly disadvantaged in fundraising. VCs are backing founders with prior exits, operating experience at top companies, or deep domain expertise. This isn't to say first-time founders can't raise-but they need to compensate with exceptional traction or a strong co-founder team with experience.

3. Regulatory and Compliance Risk Is Priced In Companies operating in regulated industries (fintech, healthtech, climate) need to demonstrate regulatory clarity or a clear path to compliance. Companies without this face valuation discounts or outright rejection.

4. AI Is Becoming Table Stakes, Not a Differentiator Every SaaS company is adding AI features. VCs are no longer impressed by "AI-powered" as a standalone pitch. They want to see how AI creates defensibility, improves unit economics, or unlocks new customer segments.

5. Distribution and Customer Acquisition Are Critical VCs are scrutinizing go-to-market strategy more closely. Companies with clear, efficient customer acquisition channels raise at premiums. Companies with vague GTM strategies face skepticism.

For founders, these shifts have practical implications. Focus on unit economics, build a team with complementary experience, understand regulatory requirements, and articulate a clear go-to-market strategy. These fundamentals matter more than ever.

What Founders Should Learn from February 2026

If you're raising capital in 2026, here are the key lessons from February:

1. Traction is the best fundraising tool. Revenue, user growth, customer traction-these beat any pitch deck. If you can show $10K MRR or 5K weekly active users, investors will listen. If you can't, focus on building before raising.

2. Valuations are correcting, so plan accordingly. If you're raising seed or Series A, expect lower valuations than 2021-2023. Plan your cap table with this in mind. If you're raising late-stage and have strong metrics, you may maintain multiples.

3. Founder quality matters more than ever. If you're a first-time founder, build an exceptional co-founder team and demonstrate deep domain expertise. If you have prior exits or operating experience, lead with that.

4. Category matters, but fundamentals matter more. AI and fintech are well-funded, but that doesn't guarantee success. Consumer apps are harder to raise in, but not impossible. Focus on building a defensible, capital-efficient business in any category.

5. Regulatory clarity is valuable. If you're operating in a regulated space, understand the regulatory landscape and communicate a clear path to compliance. This de-risks your company and increases valuation.

6. Unit economics are non-negotiable. VCs will scrutinize your CAC, LTV, retention, and payback period. Ensure these metrics are defensible before pitching. If they're not, focus on improving them before raising.

7. Go-to-market strategy matters. VCs want to see a clear, efficient path to customers. If your GTM is vague or reliant on virality, you'll face skepticism. Articulate a concrete acquisition strategy.

For more tactical guidance, explore pitch deck red flags and capital raising plans to ensure you're positioned correctly.

Looking Ahead: What to Expect in March and Beyond

February's deal activity and valuation trends suggest several dynamics for the coming months:

1. Series A will tighten further. With seed cohort quality declining, Series A investors will become more selective. The success rate for Series A fundraising will likely decline further.

2. AI infrastructure will consolidate. The mega-rounds in AI infrastructure will accelerate consolidation. Smaller AI startups will face pressure to raise, acquire, or pivot.

3. Fintech infrastructure will remain hot. Regulatory tailwinds and clear ROI will keep fintech infrastructure well-funded. Consumer fintech will remain under pressure.

4. Climate tech will see sustained capital flow. Patient capital from mega-funds will continue deploying into climate tech. This category will remain well-funded through 2026.

5. B2B SaaS valuations will stabilize. After months of correction, B2B SaaS valuations will stabilize around 6-7x ARR for strong companies. This is a reasonable multiple that VCs and founders can agree on.

For founders, the key is to stay informed and adapt your fundraising strategy accordingly. Join Capitaly, the AI native platform for capital raising, to get daily insights on venture, fundraising, valuations, and startup life. Read Capitaly's blog for deep dives into specific fundraising topics and emerging trends.

Conclusion: The February Takeaway

February 2026 was a month of correction and consolidation. Deal volume remained steady, but valuations tightened, investor selectivity increased, and founder quality became a key differentiator. AI infrastructure continued to dominate headlines, fintech infrastructure remained well-funded, and climate tech saw a resurgence. For founders, the message is clear: focus on fundamentals, demonstrate traction, and build a team with complementary experience.

The fundraising environment in 2026 rewards disciplined founders with strong unit economics and clear value propositions. It punishes founders who rely on hype, vague TAM arguments, or generic positioning. If you're raising capital, use February's data as a benchmark. Ensure your metrics are competitive, your pitch is tight, and your team is credible.

The window for fundraising is open, but it's narrow. Use it wisely.